Hubbell Work in process increased by 9.4% to $248.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.0%, from $224.30M to $248.90M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 19.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $120.50M | $126.20M | $129.40M | $139.80M | $149.30M | $156.50M | $161.70M | $175.20M | $175.70M | $171.20M | $189.20M | $208.10M | $214.00M | $216.40M | $218.50M | $224.30M | $220.30M | $222.70M | $227.50M | $248.90M |
| QoQ Change | — | +4.7% | +2.5% | +8.0% | +6.8% | +4.8% | +3.3% | +8.3% | +0.3% | -2.6% | +10.5% | +10.0% | +2.8% | +1.1% | +1.0% | +2.7% | -1.8% | +1.1% | +2.2% | +9.4% |
| YoY Change | — | — | — | — | +23.9% | +24.0% | +25.0% | +25.3% | +17.7% | +9.4% | +17.0% | +18.8% | +21.8% | +26.4% | +15.5% | +7.8% | +2.9% | +2.9% | +4.1% | +11.0% |
| % of Inventories | 18.9% | 18.0% | 19.5% | 19.7% | 20.8% | 21.2% | 21.8% | 22.5% | 22.1% | 21.7% | 22.7% | 24.7% | 25.0% | 25.5% | 21.6% | 26.4% | 21.4% | 21.1% | 21.0% | 21.8% |
| Share Change | — | -0.9pp | +1.5pp | +0.2pp | +1.0pp | +0.4pp | +0.7pp | +0.6pp | -0.3pp | -0.4pp | +1.0pp | +2.0pp | +0.3pp | +0.5pp | -3.8pp | +4.8pp | -5.0pp | -0.3pp | -0.1pp | +0.9pp |